1135280-28-2,MFCD24369012
Catalog No.:AA008TEE

1135280-28-2 | N-[2-({[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl](methyl)amino}methyl)phenyl]-4-methoxybenzenesulfonamide; phosphoric acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
in stock  
$497.00   $348.00
- +
10mg
in stock  
$663.00   $464.00
- +
50mg
in stock  
$1,818.00   $1,273.00
- +
200mg
in stock  
$4,097.00   $2,868.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA008TEE
Chemical Name:
N-[2-({[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl](methyl)amino}methyl)phenyl]-4-methoxybenzenesulfonamide; phosphoric acid
CAS Number:
1135280-28-2
Molecular Formula:
C24H28ClN2O7PS
Molecular Weight:
554.9801
MDL Number:
MFCD24369012
SMILES:
OP(=O)(O)O.COc1ccc(cc1)S(=O)(=O)Nc1ccccc1CN(CC=Cc1ccc(cc1)Cl)C
Properties
Computed Properties
 
Complexity:
700  
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
1  
Formal Charge:
0  
Heavy Atom Count:
36  
Hydrogen Bond Acceptor Count:
9  
Hydrogen Bond Donor Count:
4  
Isotope Atom Count:
0  
Rotatable Bond Count:
9  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  

Literature

Title: CaMKII inhibition hyperpolarizes membrane and blocks nitrergic IJP by closing a Cl(-) conductance in intestinal smooth muscle.

Journal: American journal of physiology. Gastrointestinal and liver physiology 20120715

Title: Examining the effect of the CaMKII inhibitor administration in the locus coeruleus on the naloxone-precipitated morphine withdrawal signs in rats.

Journal: Behavioural brain research 20120115

Title: Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia.

Journal: Journal of molecular and cellular cardiology 20110101

Title: Modulations of NeuroD activity contribute to the differential effects of morphine and fentanyl on dendritic spine stability.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20100616

Title: L-type Ca(2+) channel facilitation mediated by H(2)O(2)-induced activation of CaMKII in rat ventricular myocytes.

Journal: Journal of molecular and cellular cardiology 20100401

Title: CaMKII-independent effects of KN93 and its inactive analog KN92: reversible inhibition of L-type calcium channels.

Journal: Biochemical and biophysical research communications 20060714

Title: KN-93 (2-[N-(2-hydroxyethyl)]-N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine), a calcium/calmodulin-dependent protein kinase II inhibitor, is a direct extracellular blocker of voltage-gated potassium channels.

Journal: The Journal of pharmacology and experimental therapeutics 20060401

Title: Calcium signaling stimulates translation of HIF-alpha during hypoxia.

Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20060301

Title: CaM kinase II phosphorylation of slo Thr107 regulates activity and ethanol responses of BK channels.

Journal: Nature neuroscience 20060101

Title: Ca(2+)/calmodulin-protein kinase IIalpha in the trigeminal subnucleus caudalis contributes to neuropathic pain following inferior alveolar nerve transection.

Journal: Experimental neurology 20050401

Title: Visualization of synaptic Ca2+ /calmodulin-dependent protein kinase II activity in living neurons.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20050323

Title: A CaMKII/calcineurin switch controls the direction of Ca(2+)-dependent growth cone guidance.

Journal: Neuron 20040916

Title: Regulation of cyclin D1/Cdk4 complexes by calcium/calmodulin-dependent protein kinase I.

Journal: The Journal of biological chemistry 20040409

Title: Roles of CaMKII, PKA, and PKC in the induction and maintenance of LTP of C-fiber-evoked field potentials in rat spinal dorsal horn.

Journal: Journal of neurophysiology 20040301

Title: Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions.

Journal: Diabetes 20040201

Title: Reversal of morphine antinociceptive tolerance by acute spinal inhibition of Ca(2+)/calmodulin-dependent protein kinase II.

Journal: European journal of pharmacology 20030328

Title: Calcium/calmodulin-dependent kinase II is involved in the facilitating effect of clozapine on NMDA- and electrically evoked responses in the medial prefrontal cortical pyramidal cells.

Journal: Synapse (New York, N.Y.) 20030315

Title: Cellular mechanisms of the acute increase of glutamate release induced by nerve growth factor in rat cerebral cortex.

Journal: Neuropharmacology 20030301

Title: Calcium-calmodulin-dependent protein kinase II contributes to spinal cord central sensitization.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20020515

Title: KN-93 inhibition of G protein signaling is independent of the ability of Ca2+/calmodulin-dependent protein kinase II to phosphorylate phospholipase Cbeta3 on 537-Ser.

Journal: Molecular and cellular endocrinology 20010425

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1135280-28-2 Molecular Formula|1135280-28-2 MDL|1135280-28-2 SMILES|1135280-28-2 N-[2-({[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl](methyl)amino}methyl)phenyl]-4-methoxybenzenesulfonamide; phosphoric acid
Catalog No.: AA008TEE
1135280-28-2,MFCD24369012
1135280-28-2 | N-[2-({[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl](methyl)amino}methyl)phenyl]-4-methoxybenzenesulfonamide; phosphoric acid
Pack Size: 5mg
Purity:
in stock
$497.00 $348.00
Pack Size: 10mg
Purity:
in stock
$663.00 $464.00
Pack Size: 50mg
Purity:
in stock
$1,818.00 $1,273.00
Pack Size: 200mg
Purity:
in stock
$4,097.00 $2,868.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA008TEE
Chemical Name: N-[2-({[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl](methyl)amino}methyl)phenyl]-4-methoxybenzenesulfonamide; phosphoric acid
CAS Number: 1135280-28-2
Molecular Formula: C24H28ClN2O7PS
Molecular Weight: 554.9801
MDL Number: MFCD24369012
SMILES: OP(=O)(O)O.COc1ccc(cc1)S(=O)(=O)Nc1ccccc1CN(CC=Cc1ccc(cc1)Cl)C
Properties
Complexity: 700  
Covalently-Bonded Unit Count: 2  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 1  
Formal Charge: 0  
Heavy Atom Count: 36  
Hydrogen Bond Acceptor Count: 9  
Hydrogen Bond Donor Count: 4  
Isotope Atom Count: 0  
Rotatable Bond Count: 9  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
Literature fold

Title: CaMKII inhibition hyperpolarizes membrane and blocks nitrergic IJP by closing a Cl(-) conductance in intestinal smooth muscle.

Journal: American journal of physiology. Gastrointestinal and liver physiology20120715

Title: Examining the effect of the CaMKII inhibitor administration in the locus coeruleus on the naloxone-precipitated morphine withdrawal signs in rats.

Journal: Behavioural brain research20120115

Title: Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia.

Journal: Journal of molecular and cellular cardiology20110101

Title: Modulations of NeuroD activity contribute to the differential effects of morphine and fentanyl on dendritic spine stability.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience20100616

Title: L-type Ca(2+) channel facilitation mediated by H(2)O(2)-induced activation of CaMKII in rat ventricular myocytes.

Journal: Journal of molecular and cellular cardiology20100401

Title: CaMKII-independent effects of KN93 and its inactive analog KN92: reversible inhibition of L-type calcium channels.

Journal: Biochemical and biophysical research communications20060714

Title: KN-93 (2-[N-(2-hydroxyethyl)]-N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine), a calcium/calmodulin-dependent protein kinase II inhibitor, is a direct extracellular blocker of voltage-gated potassium channels.

Journal: The Journal of pharmacology and experimental therapeutics20060401

Title: Calcium signaling stimulates translation of HIF-alpha during hypoxia.

Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology20060301

Title: CaM kinase II phosphorylation of slo Thr107 regulates activity and ethanol responses of BK channels.

Journal: Nature neuroscience20060101

Title: Ca(2+)/calmodulin-protein kinase IIalpha in the trigeminal subnucleus caudalis contributes to neuropathic pain following inferior alveolar nerve transection.

Journal: Experimental neurology20050401

Title: Visualization of synaptic Ca2+ /calmodulin-dependent protein kinase II activity in living neurons.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience20050323

Title: A CaMKII/calcineurin switch controls the direction of Ca(2+)-dependent growth cone guidance.

Journal: Neuron20040916

Title: Regulation of cyclin D1/Cdk4 complexes by calcium/calmodulin-dependent protein kinase I.

Journal: The Journal of biological chemistry20040409

Title: Roles of CaMKII, PKA, and PKC in the induction and maintenance of LTP of C-fiber-evoked field potentials in rat spinal dorsal horn.

Journal: Journal of neurophysiology20040301

Title: Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions.

Journal: Diabetes20040201

Title: Reversal of morphine antinociceptive tolerance by acute spinal inhibition of Ca(2+)/calmodulin-dependent protein kinase II.

Journal: European journal of pharmacology20030328

Title: Calcium/calmodulin-dependent kinase II is involved in the facilitating effect of clozapine on NMDA- and electrically evoked responses in the medial prefrontal cortical pyramidal cells.

Journal: Synapse (New York, N.Y.)20030315

Title: Cellular mechanisms of the acute increase of glutamate release induced by nerve growth factor in rat cerebral cortex.

Journal: Neuropharmacology20030301

Title: Calcium-calmodulin-dependent protein kinase II contributes to spinal cord central sensitization.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience20020515

Title: KN-93 inhibition of G protein signaling is independent of the ability of Ca2+/calmodulin-dependent protein kinase II to phosphorylate phospholipase Cbeta3 on 537-Ser.

Journal: Molecular and cellular endocrinology20010425

Building Blocks More >
1191911-27-9
1191911-27-9
N-{2-[(5-chloro-2-{[2-methoxy-4-(morpholin-4-yl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}methanesulfonamide
AA008TIV | MFCD26401527
1174018-99-5
1174018-99-5
Relebactam
AA008TMP | MFCD28502833
104163-39-5
104163-39-5
(4-Methyl-2-thienyl)methylamine
AA008TVL | MFCD06657973
1159511-16-6
1159511-16-6
Thieno[3,2-c]pyridin-3-amine
AA008U43 | MFCD11869738
1171790-84-3
1171790-84-3
4-Dimethylaminophenylglyoxal hydrate
AA008UDU | MFCD24393347
1111732-84-3
1111732-84-3
Potassium 3,5-dimethylisoxazole-4-yltrifluoroborate
AA008UO3 | MFCD09993005
118584-90-0
118584-90-0
Fmoc-Lys(dansyl)-OH
AA008UY5 | MFCD00672343
1170110-01-6
1170110-01-6
1-Methyl-1,3-diazaspiro[4.4]nonane-2,4-dione
AA008V5I | MFCD12402125
1170258-35-1
1170258-35-1
5-[(4-Methyl-1h-pyrazol-1-yl)methyl]isoxazole-3-carboxylic acid
AA008VB0 | MFCD12027289
105985-16-8
105985-16-8
2-Amino-N-hydroxy-2-phenylacetamide
AA008VFZ | MFCD00243468
Submit
© 2017 AA BLOCKS, INC. All rights reserved.